Seres Therapeutics, Inc. Quarterly Operating Margin in % from Q4 2016 to Q2 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Seres Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2016 to Q2 2024.
  • Seres Therapeutics, Inc. Operating Margin for the quarter ending June 30, 2024 was -42.2K %, a 36968% decline year-over-year.
  • Seres Therapeutics, Inc. annual Operating Margin for 2023 was -85.5 %, a 97.5% increase from 2022.
  • Seres Therapeutics, Inc. annual Operating Margin for 2022 was -3.46K %, a 7671% decline from 2021.
  • Seres Therapeutics, Inc. annual Operating Margin for 2021 was -44.5 %, a 83.2% increase from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -42.2K -42.1K -36968% Apr 1, 2024 Jun 30, 2024
Q1 2024 -60.7 +5.05K +98.8% Jan 1, 2024 Mar 31, 2024
Q4 2023 -85.5 +3.37K +97.5% Oct 1, 2023 Dec 31, 2023
Q3 2023 -105 +1.6K +93.8% Jul 1, 2023 Sep 30, 2023
Q2 2023 -114 -40.6 -55.5% Apr 1, 2023 Jun 30, 2023
Q1 2023 -5.11K -5.05K -8368% Jan 1, 2023 Mar 31, 2023
Q4 2022 -3.46K -3.41K -7671% Oct 1, 2022 Dec 31, 2022
Q3 2022 -1.7K -1.68K -7918% Jul 1, 2022 Sep 30, 2022
Q2 2022 -73.3 +365 +83.3% Apr 1, 2022 Jun 30, 2022
Q1 2022 -60.4 +277 +82.1% Jan 1, 2022 Mar 31, 2022
Q4 2021 -44.5 +221 +83.2% Oct 1, 2021 Dec 31, 2021
Q3 2021 -21.2 +363 +94.5% Jul 1, 2021 Sep 30, 2021
Q2 2021 -438 -173 -65.3% Apr 1, 2021 Jun 30, 2021
Q1 2021 -338 -148 -78.2% Jan 1, 2021 Mar 31, 2021
Q4 2020 -265 -57 -27.4% Oct 1, 2020 Dec 31, 2020
Q3 2020 -384 -186 -93.8% Jul 1, 2020 Sep 30, 2020
Q2 2020 -265 -64.4 -32.1% Apr 1, 2020 Jun 30, 2020
Q1 2020 -189 +116 +38% Jan 1, 2020 Mar 31, 2020
Q4 2019 -208 +146 +41.3% Oct 1, 2019 Dec 31, 2019
Q3 2019 -198 +326 +62.2% Jul 1, 2019 Sep 30, 2019
Q2 2019 -201 +69 +25.6% Apr 1, 2019 Jun 30, 2019
Q1 2019 -305 -21.8 -7.67% Jan 1, 2019 Mar 31, 2019
Q4 2018 -355 -70.1 -24.6% Oct 1, 2018 Dec 31, 2018
Q3 2018 -524 -252 -92.5% Jul 1, 2018 Sep 30, 2018
Q2 2018 -270 +179 +39.9% Apr 1, 2018 Jun 30, 2018
Q1 2018 -284 +164 +36.6% Jan 1, 2018 Mar 31, 2018
Q4 2017 -285 +142 +33.2% Oct 1, 2017 Dec 31, 2017
Q3 2017 -272 Jul 1, 2017 Sep 30, 2017
Q2 2017 -449 Apr 1, 2017 Jun 30, 2017
Q1 2017 -448 Jan 1, 2017 Mar 31, 2017
Q4 2016 -427 Oct 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.